Alvotech: Rubric Capital Management LP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Rubric Capital Management LP disclosed a stake of more than 5% in Alvotech in a Schedule 13G filing with the SEC (accession 0001104659-26-128298). The exact share count and percentage were not specified in the headline disclosure. The move signals active institutional interest in the biosimilars developer. Investors will watch for the full 13G details, including share count and whether the position is passive, and for any subsequent 13D or 13G amendments.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Alvotech, Rubric Capital Management LP